Analyst Price Targets — PTEN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 11:58 am | — | Morgan Stanley | $11.00 | $9.85 | TheFly | Patterson-UTI price target raised to $11 from $10 at Morgan Stanley |
| July 8, 2026 11:55 am | Charles Minervino | Susquehanna | $12.00 | $9.15 | TheFly | Patterson-UTI price target lowered to $12 from $14 at Susquehanna |
| June 16, 2026 9:23 am | Stephen Gengaro | Stifel Nicolaus | $15.00 | $10.66 | StreetInsider | Patterson-UTI Energy (PTEN) PT Raised to $15 at Stifel |
| June 3, 2026 11:07 pm | — | Goldman Sachs | $13.00 | $12.01 | TheFly | Patterson-UTI price target lowered to $13 from $23 at Goldman Sachs |
| May 27, 2026 11:10 am | — | Piper Sandler | $13.00 | $12.12 | TheFly | Patterson-UTI price target raised to $13 from $12 at Piper Sandler |
| May 27, 2026 11:02 am | — | Susquehanna | $14.00 | $12.12 | TheFly | Patterson-UTI price target raised to $14 from $13 at Susquehanna |
| April 27, 2026 10:38 am | — | Barclays | $10.00 | $11.33 | TheFly | Patterson-UTI price target raised to $10 from $8 at Barclays |
| April 24, 2026 12:14 pm | — | Stifel Nicolaus | $14.00 | $11.14 | TheFly | Patterson-UTI price target raised to $14 from $11 at Stifel |
| April 20, 2026 12:45 pm | — | Capital One Financial | $12.00 | $9.72 | TheFly | Patterson-UTI upgraded to Overweight from Equalweight at Capital One |
| April 15, 2026 11:27 am | Joe Laetsch | Morgan Stanley | $10.00 | $9.88 | TheFly | Patterson-UTI price target raised to $10 from $7 at Morgan Stanley |
Latest News for PTEN
Patterson-UTI (PTEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Escalating U.S.-Iran tensions are lifting oil prices, while HAL and PTEN remain below industry EV/EBITDA averages after strong rallies.
IRVING, Texas, July 14, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced it will offer in-house PTEN immunohistochemistry (IHC) testing following the recent FDA approval of a biomarker-guided therapy and companion diagnostic assay. This testing is designed to help identify patients with PTEN-deficient…
HOUSTON, TX / ACCESS Newswire / July 9, 2026 / PATTERSON-UTI ENERGY, INC. (NASDAQ:PTEN) will host a conference call on Thursday, July 30, 2026, at 9:00 a.m.
Here is how Patterson-UTI (PTEN) and Suncor Energy (SU) have performed compared to their sector so far this year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.